Contact
KICKSTART YOUR MEDTECH PROJECT

The Seed Program

Stories land funding. Through the Seed program, we help you create the story presents a clear improvement over the standard of care. It starts by defining the clinical and economic value propositions and creating a clear and compelling medical device vision.

Curious to learn if the Seed program is right for you? Request a free medtech consultation to find out.

REQUEST CONSULTATION
WHAT'S IN IT FOR YOUR COMPANY?

Impact to your business

The Seed program will help you clearly articulate how your medtech innovation offers a clinical and economic improvement over the standard of care. You will come out of the Seed program with a clear vision, a compelling business proposition, and a convincing story that attracts investment.

WHAT'S IN IT FOR THE OTHERS?

Impact to your investors

Your investors care about risks and returns. The Seed program focuses on both. We will help you identify the technical, clinical, regulatory, reimbursement, and manufacturing risk factors. Then, we will help you develop a vetted plan to address these risks and build market value. We will help you capture the market opportunity and weave it into a story that resonates with investors and other stakeholders.

How it works

Our medtech experts follow a proven process that has consistently delivered reliable results for early-stage medtech innovators. You will be an active participant in this process, providing early insights, and helping shape the strategy. 

INTAKE QUESTIONNAIRE

We start with what you know. Our questionnaire efficiently captures the insights you have already collected and identifies potential gaps requiring additional research.

MEDTECH CANVAS

Next, we create a 1-page strategic plan together. Boiling your medtech strategy down to a single page forces us to capture the key elements, identify the gaps. and build a clear vision.

DRAFT PITCHDECK

Next, we create a comprehensive pitchdeck that wraps your medtech story with product illustrations to define the use case, the value proposition, and the plan to make it real.

FINAL PITCHDECK

We collect your feedback, update the slides, and refine the medtech story. When complete, your medtech strategy and pitchdeck will be trialed, vetted, and investor ready. 

KEY PROGRAM OUTPUTS

What you get

The Seed program provides clinical, economic, market, regulatory, and commercial details into a comprehensive strategic plan and investor ready pitchdeck.

  1. Clear clinical value proposition in comparison with standard of care
  2. Healthcare economic story that illustrates a clear cost benefit
  3. Product illustrations that communicate the use case and the clinical benefit
  4. Development plan inclusive of technical, pre-clinical, clinical, regulatory, and manufacturing pathways
  5. Quantified market opportunity focused on the target clinical indication
  6. Investor-ready pitch deck that weaves together a clear and compelling opportunity
FREE CONSULTATION

How can you create a focused strategy that unlocks funding?

To find out, request a free medtech consultation.

REQUEST CONSULTATION
DIRECTOR, PPDC

Robert Levy, MD

"As Director of the FDA's Pennsylvania Pediatric Medical Device Consortium (PPDC), I have seen Archimedic help early-stage pediatric medical device ideas come to fruition. They have all the expertise, experience, and tools to make this happen."

CEO, ORVAC

Tyiwanna Carter

"As a first-time inventor and company founder without any engineering or medical background, I was initially overwhelmed about the medical device development process. Archimedic helped clarify this process, created a compelling vision for the Orvac, and developed a comprehensive plan for achieving my longer-term business milestones. With Archimedic's help, I was able to secure additional funding to advance the Orvac to continue product development and commercialization milestones."

CEO, BASIL LEAF TECHNOLOGIES

Basil Harris, MD, PhD

"It's been great working with Archimedic because they've been able to get us focused and on track in a very logical trajectory. I was trying to go all directions at the same time, and it was really not sustainable."